Factdock Insights

Makamashi da yanayi

Ƙa'idojin makamashi, manufar grid da yanayi, da sanarwar masana'antu da ke biyo baya.

Raba
An sabunta · 2026-09-20 22:10 UTC38
Babban labarin yau

Specialised Therapeutics Ta Fadada Haɗin gwiwa da Incyte don Haɗa Ruxolitinib Cream (Opzelura®) a Ostiraliya

SINGAPORE, Satumba 20, 2026 /PRNewswire/ -- Kamfanin biopharmaceutical mai zaman kansa Specialised Therapeutics (ST) a yau ya sanar da fadada haɗin gwiwarsa da Incyte Biosciences International, wani reshe na Incyte (NASDAQ: INCY), don kasuwanci, rarrabawa, da rajista...

Makamashi da yanayiAyyukan da ake kan yi da ci gabaPR Newswire (Health)
Karanta tushen
Makamashi da yanayiAyyukan da ake kan yi da ci gabaPR Newswire (Health)

JACC: Clinical Electrophysiology ta Bugawa Sakamakon Watanni 12 na Nazarin Farko na Field PULSE na Field Medical: 94.2% PVI Dorewa ga Kowane Jijiya tare da Ingantaccen Tsarin Wave

Sabbin bayanan HRX sun inganta aikin "Instantaneous Ablation" na Field Medical kuma sun fadada shaidar asibiti don High-voltage Focal PFA tare da tsarin FieldForce™-PFA. ATLANTA da CARLSBAD, California, Satumba 20, 2026 /PRNewswire/ -- Field Medical, Inc., wani...

Karanta tushen
Makamashi da yanayiAyyukan da ake kan yi da ci gabaPR Newswire (Health)

JACC: Clinical Electrophysiology ta buga sakamakon watanni 12 na gwajin Field PULSE na farko a cikin mutane na Field Medical: 94.2% na dorewar warewar jijiyoyin huhu, ta kowane jijiya, godiya ga siffar igiyar ruwa

Bayanan da aka gabatar a HRX sun inganta tsarin "ablation nan take" na Field Medical kuma sun fadada bayanan asibiti game da ablation filin bugun jini (PFA) mai karfin wutar lantarki tare da tsarin PFA na FieldForce™ ATLANTA da CARLSBAD, California, 20...

Karanta tushen

Bayanan hukuma

Ƙa'idoji da sanarwa da aka tabbatar daga hukumomin gwamnati, masu kula da ƙa'ida da jaridun hukuma.

Karanta kowane bayani da yarenka

Wannan shafi yana nuna sabbin abubuwa uku ne kawai a kowane fanni. Mambobi na ganin kowane bayani a cikin fannin, a harsuna 109, tare da injinan bincike da ke aiki a kansu.

Karanta duka kan $29

Babu buƙatar shigarwa daga kantin manhajoji. Ana iya soke shi kowane lokaci.

Sabbin abubuwa a kowane fanni

Kowane abu yana da haɗi zuwa cibiyar da ta wallafa shi. Ba a sake rubuta komai ba tare da tushensa ba.